Hospital Corporation of China Limited (HKG:3869)
Hong Kong · Delayed Price · Currency is HKD 5.14
0.00 (0.00%)
At close: Feb 13, 2026
HKG:3869 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 1,466 | 1,442 | 1,428 | 1,143 | 520.29 | 399.21 | |
Revenue Growth (YoY) | 2.55% | 1.02% | 24.92% | 119.68% | 30.33% | -2.84% |
Cost of Revenue | 1,196 | 1,166 | 1,188 | 992.07 | 306.06 | 204.89 |
Gross Profit | 270.25 | 275.82 | 239.36 | 150.88 | 214.23 | 194.33 |
Selling, General & Admin | 121.71 | 109.12 | 130.8 | 95.5 | 97.88 | 51.9 |
Other Operating Expenses | -12.57 | -13.53 | -17.05 | 18.66 | 17.91 | -62.52 |
Operating Expenses | 109.14 | 95.58 | 113.75 | 114.16 | 115.78 | -10.62 |
Operating Income | 161.11 | 180.24 | 125.61 | 36.71 | 98.44 | 204.95 |
Interest Expense | -9.1 | -2.58 | -2.46 | -4.91 | -6.09 | -13.06 |
Interest & Investment Income | 10.19 | 10.53 | 9.74 | 8.99 | 6.73 | 18.42 |
Currency Exchange Gain (Loss) | - | - | - | 5.61 | -13.35 | -34.75 |
Other Non Operating Income (Expenses) | 38.61 | -128.54 | -141.84 | -0.06 | -1.32 | -6.59 |
EBT Excluding Unusual Items | 200.8 | 59.65 | -8.95 | 46.35 | 84.42 | 168.97 |
Impairment of Goodwill | - | - | - | -362.82 | -141.27 | -467.08 |
Gain (Loss) on Sale of Investments | 1.48 | 1.62 | 2.23 | 5.72 | 5.76 | 2.55 |
Gain (Loss) on Sale of Assets | - | - | - | -0.65 | -0.14 | -2.23 |
Asset Writedown | - | - | - | -97.46 | -410.71 | -201.14 |
Other Unusual Items | 0.72 | - | 222.92 | -123.76 | 12.84 | 63.1 |
Pretax Income | 203 | 61.27 | 216.2 | -532.63 | -449.1 | -435.82 |
Income Tax Expense | 44.16 | 47.48 | 47.86 | -4.03 | -86.71 | -14.75 |
Earnings From Continuing Operations | 158.84 | 13.79 | 168.34 | -528.6 | -362.4 | -421.07 |
Net Income to Company | 158.84 | 13.79 | 168.34 | -528.6 | -362.4 | -421.07 |
Minority Interest in Earnings | -23.11 | -52.42 | -36.96 | 47.65 | 81.69 | 16.73 |
Net Income | 135.74 | -38.63 | 131.38 | -480.95 | -280.71 | -404.34 |
Net Income to Common | 135.74 | -38.63 | 131.38 | -480.95 | -280.71 | -404.34 |
Shares Outstanding (Basic) | 137 | 137 | 137 | 138 | 138 | 138 |
Shares Outstanding (Diluted) | 169 | 137 | 202 | 138 | 138 | 138 |
Shares Change (YoY) | 23.50% | -32.20% | 46.29% | - | - | -31.87% |
EPS (Basic) | 0.99 | -0.28 | 0.96 | -3.48 | -2.03 | -2.93 |
EPS (Diluted) | 0.18 | -0.28 | 0.21 | -3.48 | -2.03 | -2.93 |
Free Cash Flow | 181.08 | 196.87 | 68.7 | 127.55 | 120.65 | 74.47 |
Free Cash Flow Per Share | 1.07 | 1.44 | 0.34 | 0.92 | 0.87 | 0.54 |
Gross Margin | 18.44% | 19.12% | 16.77% | 13.20% | 41.17% | 48.68% |
Operating Margin | 10.99% | 12.50% | 8.80% | 3.21% | 18.92% | 51.34% |
Profit Margin | 9.26% | -2.68% | 9.20% | -42.08% | -53.95% | -101.28% |
Free Cash Flow Margin | 12.35% | 13.65% | 4.81% | 11.16% | 23.19% | 18.66% |
EBITDA | 218.65 | 236.54 | 187.6 | 95.45 | 136.2 | 244.49 |
EBITDA Margin | 14.92% | 16.40% | 13.14% | 8.35% | 26.18% | 61.24% |
D&A For EBITDA | 57.54 | 56.31 | 61.99 | 58.73 | 37.75 | 39.54 |
EBIT | 161.11 | 180.24 | 125.61 | 36.71 | 98.44 | 204.95 |
EBIT Margin | 10.99% | 12.50% | 8.80% | 3.21% | 18.92% | 51.34% |
Effective Tax Rate | 21.75% | 77.49% | 22.14% | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.